China Shineway Pharmaceutical Group Limited (FRA:C1S)

FRA:C1S Revenue

China Shineway Pharmaceutical Group had revenue of 1.65B CNY in the half year ending June 30, 2025, a decrease of -31.10%. This brings the company's revenue in the last twelve months to 3.34B, down -20.47% year-over-year. In the year 2024, China Shineway Pharmaceutical Group had annual revenue of 3.78B, down -16.35%.

• Revenue (ttm): 3.34B CNY
• Revenue Growth: -20.47%
• P/S Ratio: 1.94
• Revenue / Employee: 1.17M CNY
• Employees: 2,867
• Market Cap: 770.17M EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.78B	-738.50M	-16.35%
Dec 31, 2023	4.52B	565.90M	14.32%
Dec 31, 2022	3.95B	727.09M	22.56%
Dec 31, 2021	3.22B	567.85M	21.38%
Dec 31, 2020	2.66B	-50.30M	-1.86%